Evidence map›Paper›PMID 31263462›Full record

ArticleFrontiers in immunology2019

EuroFlow-Based Flowcytometric Diagnostic Screening and Classification of Primary Immunodeficiencies of the Lymphoid System.

Jacques J M van Dongen, Mirjam van der Burg, Tomas Kalina, Martin Perez-Andres, Ester Mejstrikova, Marcela Vlkova, Eduardo Lopez-Granados, Marjolein Wentink, Anne-Kathrin Kienzler, Jan Philippé and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Effects of two different variants in theFrontiers in immunology · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Reference values of lymphocyte subsets from healthy Polish adults.Central-European journal of immunology · 2024
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 7 countries.

Jacques J M van DongenDepartment of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, Netherlands.
Mirjam van der BurgDepartment of Immunology, Erasmus MC, Rotterdam, Netherlands.
Tomas KalinaDepartment of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, Prague, Czechia.
Martin Perez-AndresDepartment of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Ester MejstrikovaDepartment of Pediatric Hematology and Oncology, University Hospital Motol, Charles University, Prague, Czechia.
Marcela VlkovaInstitute of Clinical Immunology and Allergology, St. Anne's University Hospital Brno, Masaryk University, Brno, Czechia.
Eduardo Lopez-GranadosDepartment of Immunology, Hospital Universitario La Paz, Madrid, Spain.
Marjolein WentinkDepartment of Immunology, Erasmus MC, Rotterdam, Netherlands.
Anne-Kathrin KienzlerExperimental Medicine Division, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.
Jan PhilippéDepartment of Laboratory Medicine, University Hospital Ghent, Ghent, Belgium.
Ana E SousaFaculdade de Medicina, Instituto de Medicina Molecular, Universidade de Lisboa, Lisbon, Portugal.
Menno C van ZelmDepartment of Immunology, Erasmus MC, Rotterdam, Netherlands.
Elena BlancoDepartment of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Alberto OrfaoDepartment of Medicine, Cancer Research Centre (IBMCC, USAL-CSIC), Cytometry Service (NUCLEUS), University of Salamanca (USAL), Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Centro de Investigación Biomédica en Red de Cáncer · ESCharles University · CZErasmus University Rotterdam · NLCentre for Biomedical Network Research on Rare Diseases · ESErasmus MC · NLGhent University Hospital · BEHospital Universitario La Paz · ESLeiden University Medical Center · NLMasaryk University · CZUniversity of Lisbon · PTUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Guidelines for screening for primary immunodeficiencies (PID) are well-defined and several consensus diagnostic strategies have been proposed. These consensus proposals have only partially been implemented due to lack of standardization in laboratory procedures, particularly in flow cytometry. The main objectives of the EuroFlow Consortium were to innovate and thoroughly standardize the flowcytometric techniques and strategies for reliable and reproducible diagnosis and classification of PID of the lymphoid system. The proposed EuroFlow antibody panels comprise one orientation tube and seven classification tubes and corresponding databases of normal and PID samples. The 8-color 12-antibody PID Orientation tube (PIDOT) aims at identification and enumeration of the main lymphocyte and leukocyte subsets; this includes naïve pre-germinal center (GC) and antigen-experienced post-GC memory B-cells and plasmablasts. The seven additional 8(-12)-color tubes can be used according to the EuroFlow PID algorithm in parallel or subsequently to the PIDOT for more detailed analysis of B-cell and T-cell subsets to further classify PID of the lymphoid system. The Pre-GC, Post-GC, and immunoglobulin heavy chain (IgH)-isotype B-cell tubes aim at identification and enumeration of B-cell subsets for evaluation of B-cell maturation blocks and specific defects in IgH-subclass production. The severe combined immunodeficiency (SCID) tube and T-cell memory/effector subset tube aim at identification and enumeration of T-cell subsets for assessment of T-cell defects, such as SCID. In case of suspicion of antibody deficiency, PIDOT is preferably directly combined with the IgH isotype tube(s) and in case of SCID suspicion (e.g., in newborn screening programs) the PIDOT is preferably directly combined with the SCID T-cell tube. The proposed ≥8-color antibody panels and corresponding reference databases combined with the EuroFlow PID algorithm are designed to provide fast, sensitive and cost-effective flowcytometric diagnosis of PID of the lymphoid system, easily applicable in multicenter diagnostic settings world-wide.

Indexed as

AdolescentAdultAgedB-LymphocytesChildChild, PreschoolFemaleFlow CytometryHumansImmunologic MemoryInfantInfant, NewbornLeukocytesLymphocytesMaleMiddle AgedclassificationdiagnosisEuroFlowflow cytometryimmunodeficiencyimmunophenotypingstandardization

Identifiers

PMID31263462
PMCPMC6585843
OpenAlexW2951551261

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.